iTeos Therapeutics, Inc. (ITOS)
NASDAQ: ITOS · Real-Time Price · USD
7.42
+0.20 (2.77%)
At close: Dec 20, 2024, 4:00 PM
7.45
+0.03 (0.41%)
After-hours: Dec 20, 2024, 7:29 PM EST
iTeos Therapeutics Market Cap
iTeos Therapeutics has a market cap or net worth of $271.08 million as of December 20, 2024. Its market cap has decreased by -23.56% in one year.
Market Cap
271.08M
Enterprise Value
-212.10M
1-Year Change
-23.56%
Ranking
Category
Stock Price
$7.42
Market Cap Chart
Since July 24, 2020, iTeos Therapeutics's market cap has decreased from $636.93M to $271.08M, a decrease of -57.44%. That is a compound annual growth rate of -17.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 271.08M | -30.82% |
| Dec 29, 2023 | 391.85M | -43.60% |
| Dec 30, 2022 | 694.79M | -57.70% |
| Dec 31, 2021 | 1.64B | 38.57% |
| Dec 31, 2020 | 1.19B | 86.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProQR Therapeutics | 267.30M |
| 4D Molecular Therapeutics | 267.20M |
| AC Immune | 267.14M |
| aTyr Pharma | 264.42M |
| Atea Pharmaceuticals | 264.37M |
| Bright Minds Biosciences | 263.33M |
| Senseonics Holdings | 263.13M |
| Lexicon Pharmaceuticals | 261.58M |